CONMED Corporation (NYSE:CNMD) Q3 2022 Earnings Conference Call October 26, 2022 4:30 PM ET

Company Representatives

Curt Hartman - Chair of the Board, President, Chief Executive Officer

Todd Garner - Executive Vice President, Chief Financial Officer

Conference Call Participants

Mike Matson - Needham

Young Li - Jefferies

Robbie Marcus - J.P. Morgan

Matthew Mishan - KeyBanc

Matt O'Brien - Piper Sandler

Rick Wise - Stifel

Travis Steed - Bank of America Securities

Operator

Good afternoon, everyone. Before the conference call begins, let me remind you that during this call management will be making comments and statements regarding its financial outlook, its plans and objectives. These statements represent the forward-looking statements that involve risks and uncertainties as those terms are defined under the Federal Securities Laws. Investors are cautioned that any such forward-looking statements are not guarantees for future events, performance or results. The company's actual results may differ materially from its current expectations.

Please refer to the risks and other uncertainties disclosed under the forward-looking information in today's press release, as well as the company's SEC filings for more details on the risks and uncertainties that may cause actual results to differ materially. The company disclaims any obligation to update any forward-looking statements that may be discussed during this call, except as may be required by applicable law.

You will also hear management refer to non-GAAP or adjusted measurements during this discussion. While these figures are not a substitute for GAAP measurements, management uses these figures to aid in monitoring the company's ongoing financial performances from quarter-to-quarter and year-to-year on a regular basis and for the benchmarking against other medical technology companies.

Adjusted net income and adjusted earnings from share measure the income of the company, excluding credits or charges that are considered by the company to be special or outside of its normal ongoing operation. These adjusting items are specified in the reconciliations supporting the company's earnings releases posted to the company's website.

With these required announcements completed, I will turn the call over to Curt Hartman, CONMED's Chair of the Board, President and Chief Executive Officer for opening remarks. Mr. Hartman, please go ahead.

Curt Hartman

Thank you, Lisa. Good afternoon and thank you for joining us for CONMED’s third quarter 2022 earnings call. I’m joined by Todd Garner, Executive Vice President and Chief Financial Officer. Today we will walk you through our third quarter results and our full year outlook. We will then open the call to your questions.